Surgery Partners, Inc. (NASDAQ:SGRY – Get Free Report) shares saw unusually-high trading volume on Thursday . Approximately 1,617,532 shares traded hands during trading, an increase of 103% from the previous session’s volume of 797,605 shares.The stock last traded at $20.42 and had previously closed at $20.35.
Wall Street Analysts Forecast Growth
SGRY has been the topic of several analyst reports. Bank of America began coverage on shares of Surgery Partners in a research note on Monday, December 16th. They set a “buy” rating and a $30.00 price target on the stock. Macquarie reaffirmed an “outperform” rating and set a $34.00 price objective on shares of Surgery Partners in a report on Tuesday, November 19th. UBS Group began coverage on shares of Surgery Partners in a report on Monday, October 14th. They set a “buy” rating and a $38.00 price objective for the company. KeyCorp began coverage on shares of Surgery Partners in a report on Friday, October 11th. They set a “sector weight” rating for the company. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $43.00 price objective on shares of Surgery Partners in a report on Friday, October 4th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $36.56.
Read Our Latest Stock Analysis on Surgery Partners
Surgery Partners Trading Down 1.4 %
Surgery Partners (NASDAQ:SGRY – Get Free Report) last issued its quarterly earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.06). The company had revenue of $770.40 million during the quarter, compared to the consensus estimate of $768.99 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. Surgery Partners’s revenue for the quarter was up 14.3% on a year-over-year basis. During the same period last year, the company earned $0.15 earnings per share. As a group, analysts forecast that Surgery Partners, Inc. will post 0.71 earnings per share for the current year.
Hedge Funds Weigh In On Surgery Partners
A number of hedge funds and other institutional investors have recently made changes to their positions in SGRY. Principal Financial Group Inc. acquired a new stake in shares of Surgery Partners during the 3rd quarter worth about $1,469,000. King Street Capital Management L.P. acquired a new stake in shares of Surgery Partners during the 3rd quarter worth about $46,748,000. Royce & Associates LP increased its position in shares of Surgery Partners by 12.2% during the 3rd quarter. Royce & Associates LP now owns 510,261 shares of the company’s stock worth $16,451,000 after purchasing an additional 55,545 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Surgery Partners by 2.4% during the 3rd quarter. Geode Capital Management LLC now owns 1,864,346 shares of the company’s stock worth $60,117,000 after purchasing an additional 42,897 shares in the last quarter. Finally, Victory Capital Management Inc. increased its position in shares of Surgery Partners by 140.4% during the 3rd quarter. Victory Capital Management Inc. now owns 1,330,399 shares of the company’s stock worth $42,892,000 after purchasing an additional 777,038 shares in the last quarter.
Surgery Partners Company Profile
Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
See Also
- Five stocks we like better than Surgery Partners
- Options Trading – Understanding Strike Price
- Bloom Energy: Powering the Future With Decentralized Energy
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.